Abstract:Background: Since 2009, a series of ambitious health system reforms have been launched in China, including the zero mark-up drug policy (ZMDP); the policy was intended to reduce substantial medicine expenses for patients by abolishing the 15% mark-up on drugs. This study aims to evaluate the impacts of ZMDP on medical expenditures from the perspective of disease burden disparities in western China. Method: Two typical diseases including Type 2 diabetes mellitus (T2DM) in internal medicine and cholecystolithiasis (CS) in surgery were selected from medical records in a large tertiary level-A hospital in SC Province. The monthly average medical expenses of patients from May 2015 to August 2018 were extracted to construct an interrupted time series (ITS) model to evaluate the impact of policy implementation on the economic burden. Results: A total of 5,764 cases were enrolled in our study. The medicine expenses for T2DM patients maintained a negative trend both before and after the intervention of ZMDP. It had declined by 74.3 CNY ( P < 0.001) per month on average in the pre-policy period and subsequently dropped to 704.4 CNY ( P = 0.028) immediately after the policy. The level change of hospitalization expenses was insignificant ( P = 0.197), with a reduction of 677.7 CNY after the policy, while the post-policy long-term trend was significantly increased by 97.7 CNY ( P = 0.035) per month contrasted with the pre-policy period. In addition, the anesthesia expenses of T2DM patients had a significant increase in the level under the impact of the policy. In comparison, the medicine expenses of CS patients significantly decreased by 1,014.2 CNY ( P < 0.001) after the policy, while the total hospitalization expenses had no significant change in level and slope under the influence of ZMDP. Furthermore, the expenses of surgery and anesthesia for CS patients significantly increased by 320.9 CNY and 331.4 CNY immediately after the policy intervention. Conclusion: Our study indicated that the ZMDP has been an effective intervention to reduce the excessive medicine expenses for both researched medical and surgical diseases, but failed to show any long-term advantage. Moreover, the policy has no significant impact on relieving the overall hospitalization burden for either condition.

Evaluation of the Effects of Global Budget Policy on Hospitalization Expenditure by Matching Difference-in-difference Model

Evaluation on the Implementation Effects of Global Budget in the Secondary and Tertiary Hospitals of Beijing

Effect Evaluation of Global Budget of Medical Insurance in Beijing

The Effects of the Multi-Hospital Global Budget Payment on Medical Expenditure and Service Volume: The Evidence from Dangyang County, China

Effect on implementation of global budge：Based on micro-data of four pilot hospitals in Beijing

The effects of global budget on cost control and readmission in rural China: a difference-in-difference analysis

Research on the effect of global budgeting in social health insurance on the tertiary hospitals in Shanghai

Strategy Analysis of the Implementation of Global Budget in the Tertiary Specialized Comprehensive Public Hospital

On the Effect of Global Budget Reform on Outpatient Drug Use in County-level Public Hospitals

Impact on Hospital Medicine After Adjusting the Drug Pricing Method

Can a global budget improve health care efficiency? Experimental evidence from China

Impact of the Global Budget Payment System on Expenditure of Cardiovascular Diseases: an Interrupted Time Series Analysis in Shanghai, China

Impacts of Price Changes on Public Hospital Reforms in China: Evidence from 25 Million Patients at Tertiary Hospitals.

The impacts of public hospital comprehensive reform policies on hospital medicine cost, revenues and healthcare expenditures 2014–2019: An analysis of 103 tertiary public hospitals in China

Effects and problems in the global budget management of health insurance in Shanghai

Substitutional Effect of Long-Term Care to Hospital Inpatient Care?

Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis

To explore a breakthrough of health reform in China through changing payment(Ⅰ):the prominent practice effects and hints of the policy called "Global budget,Structure adjustment" in Shanghai

Theoretical analysis on the behavior change of tertiary hospitals under global budgeting in Shanghai

Impact of Global Budget Combined with Pay-for-performance on the Quality of Care in County Hospitals: a Difference-in-differences Study Design with a Propensity-Score-matched Control Group Using Data from Guizhou Province, China

Expected Effects of the Mixed Payment of "global Budget and Service Unit" (Ⅱ): Purchasing Low -Price and High -Quality Drugs Will Inevitably Become Widespread Behaviors in Hospitals